Position in AMGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$8,606,868
+$935,835 QoQ
Shares Held
23,768
+9.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#608
of 3,140 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AG2R LA MONDIALE GESTION D'ACTIFS holds $140,421,019 across 9 Drug Manufacturers - General names. AMGN ranks #5 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,218 | $42,241,529 | |
| 2 | JNJ |
Johnson & Johnson
|
142,361 | $36,155,423 | |
| 3 | ABBV |
AbbVie Inc.
|
77,661 | $19,542,614 | |
| 4 | MRK |
Merck & Co., Inc.
|
108,665 | $13,963,452 | |
| 5 | AMGN |
Amgen Inc
This page
|
23,768 | $8,606,868 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
54,814 | $6,925,200 | |
| 7 | PFE |
Pfizer Inc
|
251,615 | $6,058,889 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
90,829 | $5,233,566 |
All Filings in AMGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,606,868 | 23,768 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $7,671,033 | 21,802 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $7,041,420 | 21,513 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $5,714,267 | 20,249 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,653,723 | 20,249 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $6,207,322 | 19,924 | Shares | Sole | 2025-06-26 | |
| No filing history on record for this holder in this stock. | ||||||